Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.
paper
Cited
Public
Unavailable
- Authors
- Busquets-Garcia, Arnau; Puighermanal, Emma; Pastor, Antoni; de la Torre, Rafael; Maldonado, Rafael; Ozaita, AndrΓ©s
- Year
- 2011
- Journal
- Biological psychiatry
- PMID
- 21684528
- DOI
- 10.1016/j.biopsych.2011.04.022
BACKGROUND: Cannabinoid agonists are potential therapeutic agents because of their antinociceptive and anxiolytic-like effects, although an important caveat to their use is the possible adverse responses related to memory impairment. An alternative approach to circumvent this limitation consists of enhancing the concentration of the endocannabinoids anandamide and 2-arachidonoylglycerol. METHODS: Using low doses of the specific inhibitors of the endocannabinoid metabolizing enzymes fatty acid amide hydrolase, URB597, and monoacylglycerol lipase, JZL184, we analyzed their acute and chronic effects on memory consolidation, anxiolytic-like effects, and nociception in mice (n = 6-12 per experimental group). RESULTS: We show that anandamide is a central component in the modulation of memory consolidation, whereas 2-arachidonoylglycerol is not involved in this process. Interestingly, both URB597 and JZL184 induce anxiolytic-like effects through different cannabinoid receptors. In addition, the results show that the antinociceptive and anxiolytic-like responses of both inhibitors, as well as their acute effects on memory consolidation, are maintained after chronic treatment. CONCLUSIONS: These results dissociate the role of anandamide and 2-arachidonoylglycerol in memory consolidation and anxiety and reveal the interest of cannabinoid receptor 2 as a novel target for the treatment of anxiety-related disorders.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders. | Cui C et al. | β | 2026 | β |
| Astrocytic EphB3 receptors regulate d-serine-gated synaptic plasticity and memory. | Langlais VC et al. | β | 2025 | β |
| Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy. | Pakkhesal S et al. | β | 2025 | β |
| Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation. | Loomba N et al. | β | 2025 | β |
| Gestational THC exposure perturbates hippocampal mitochondrial respiration in the memory-impaired adolescent progeny: Is there a role for mitochondrial CB1 receptor? | Lavanco G et al. | β | 2025 | β |
| Intermittent supplementation with <i>Akkermansia muciniphila</i> and galactooligosaccharides modulates Alzheimer's disease progression, gut microbiota, and colon short-chain fatty acid profiles in mice. | KuneviΔius A et al. | β | 2025 | β |
| Microglial cannabinoid receptor 2 and epigenetic regulation: Implications for the treatment of depression. | Sharma P et al. | β | 2025 | β |
| Obesogenic diet impairs memory consolidation via the hippocampal endocannabinoid system. | Ducourneau EG et al. | β | 2025 | β |
| Role of endocannabinoid neurotransmission in the insular cortex on cardiovascular, autonomic and behavioral responses evoked by acute restraint stress in rats. | Belem-Filho IJA et al. | β | 2025 | β |
| Upregulation of endocannabinoid signaling in vivo restores striatal synaptic plasticity and motor performance in Huntington's disease mice. | Sepers MD et al. | β | 2025 | β |
| Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice. | Fusse EJ et al. | β | 2024 | β |
| Cannabidiol ameliorates mitochondrial disease via PPARΞ³ activation in preclinical models. | Puighermanal E et al. | β | 2024 | β |
| Neurolipidomic insights into anxiety disorders: Uncovering lipid dynamics for potential therapeutic advances. | Maehashi S et al. | β | 2024 | β |
| Prebiotics Mitigate the Detrimental Effects of High-Fat Diet on memory, anxiety and microglia functionality in Ageing Mice. | Vijaya AK et al. | β | 2024 | β |
| Adipose tissue coregulates cognitive function. | Oliveras-CaΓ±ellas N et al. | β | 2023 | β |
| Endocannabinoid Metabolism and Transport as Drug Targets. | Ciaramellano F et al. | β | 2023 | β |
| Endocannabinoid regulation of hippocampus-dependent memory. | Figueiredo A et al. | β | 2023 | β |
| Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS. | Kouchaeknejad A et al. | β | 2023 | β |
| Inhibitors of Endocannabinoids' Enzymatic Degradation as a Potential Target of the Memory Disturbances in an Acute N-Methyl-D-Aspartate (NMDA) Receptor Hypofunction Model of Schizophrenia in Mice. | Kruk-Slomka M et al. | β | 2023 | β |
| Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism. | MartΓnez-Torres S et al. | β | 2023 | β |
| Repeated Mild Traumatic Brain Injury and JZL184 Produce Sex-Specific Increases in Anxiety-Like Behavior and Alcohol Consumption in Wistar Rats. | Jacotte-Simancas A et al. | β | 2023 | β |
| Sexual differences in locus coeruleus neurons and related behavior in C57BL/6J mice. | Mariscal P et al. | β | 2023 | β |
| The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. | Hill MN et al. | β | 2023 | β |
| The role of the endocannabinoid 2-arachidonoylglycerol in the in vivo spinal oxytocin-induced antinociception in male rats. | Salinas-Abarca AB et al. | β | 2023 | β |
| Transcriptome profiles associated with resilience and susceptibility to single prolonged stress in the locus coeruleus and nucleus accumbens in male sprague-dawley rats. | Nahvi RJ et al. | β | 2023 | β |
| Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes. | Serrano A et al. | β | 2022 | β |
| Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome. | Navarro-Romero A et al. | β | 2022 | β |
| CB2 cannabinoid receptor expression is increased in 129S1/SvImJ mice: behavioral consequences. | Ten-Blanco M et al. | β | 2022 | β |
| Coordinated Regulation of CB1 Cannabinoid Receptors and Anandamide Metabolism Stabilizes Network Activity during Homeostatic Downscaling. | Ye M et al. | β | 2022 | β |
| Disrupting GPCR Complexes with Smart Drug-like Peptides. | Gallo M et al. | β | 2022 | β |
| Hippocampal Cannabinoid 1 Receptors Are Modulated Following Cocaine Self-administration in Male Rats. | De Sa Nogueira D et al. | β | 2022 | β |
| <i>Hizikia fusiforme</i> functional oil (HFFO) prevents neuroinflammation and memory deficits evoked by lipopolysaccharide/aluminum trichloride in zebrafish. | Nie YY et al. | β | 2022 | β |
| Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain. | Della Pietra A et al. | β | 2022 | β |
| The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics. | Ahmed M et al. | β | 2022 | β |
| Tonic endocannabinoid signaling supports sleep through development in both sexes. | Martin SC et al. | β | 2022 | β |
| Cannabidiol and Neurodevelopmental Disorders in Children. | Kwan Cheung KA et al. | β | 2021 | β |
| Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches. | Kondev V et al. | β | 2021 | β |
| Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase. | Vecchiarelli HA et al. | β | 2021 | β |
| Coordinated regulation of CB1 cannabinoid receptors and anandamide metabolism stabilizes network activity during homeostatic downscaling | Ye M et al. | β | 2021 | β |
| Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. | Della Pietra A et al. | β | 2021 | β |
| Endocannabinoids, cannabinoids and the regulation of anxiety. | Petrie GN et al. | β | 2021 | β |
| Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice. | Pirbhoy PS et al. | β | 2021 | β |
| On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence. | Paredes-Ruiz KJ et al. | β | 2021 | β |
| Prospects for the Use of Cannabinoids in Psychiatric Disorders. | Graczyk M et al. | β | 2021 | β |
| Protein Kinase C-Gamma Knockout Mice Show Impaired Hippocampal Short-Term Memory While Preserved Long-Term Memory. | Gomis-GonzΓ‘lez M et al. | β | 2021 | β |
| Regulation of stress-provoked aggressive behavior using endocannabinoids. | Chang CH et al. | β | 2021 | β |
| Selective inhibition of monoacylglycerol lipase is associated with passive coping behavior and attenuation of stress-induced dopamine release in the medial prefrontal cortex. | PavΓ³n FJ et al. | β | 2021 | β |
| 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics. | Bedse G et al. | β | 2020 | β |
| An Alternative Maze to Assess Novel Object Recognition in Mice. | Da Cruz JFO et al. | β | 2020 | β |
| Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress. | Alteba S et al. | β | 2020 | β |
| A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome. | de la Torre R et al. | β | 2020 | β |
| A time-dependent contribution of hippocampal CB<sub>1</sub> , CB<sub>2</sub> and PPARΞ³ receptors to cannabidiol-induced disruption of fear memory consolidation. | Raymundi AM et al. | β | 2020 | β |
| Attenuation of fear-conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB<sub>2</sub> receptors. | Corcoran L et al. | β | 2020 | β |
| Cannabinoid CB<sub>2</sub> receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear. | Ivy D et al. | β | 2020 | β |
| CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition. | Rojo-Bustamante E et al. | β | 2020 | β |
| Disease-modifying effects of natural Ξ9-tetrahydrocannabinol in endometriosis-associated pain. | Escudero-Lara A et al. | β | 2020 | β |
| Endocannabinoid System Components as Potential Biomarkers in Psychiatry. | Navarrete F et al. | β | 2020 | β |
| Functional and molecular heterogeneity of D2R neurons along dorsal ventral axis in the striatum. | Puighermanal E et al. | β | 2020 | β |
| Monoacylglycerol lipase alpha inhibition alters prefrontal cortex excitability and blunts the consequences of traumatic stress in rat. | Worley NB et al. | β | 2020 | β |
| Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor. | Wyatt RM et al. | β | 2020 | β |
| Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications. | Grimsey NL et al. | β | 2020 | β |
| Specific Hippocampal Interneurons Shape Consolidation of Recognition Memory. | Oliveira da Cruz JF et al. | β | 2020 | β |
| Acute Administration of URB597 Fatty Acid Amide Hydrolase Inhibitor Prevents Attentional Impairments by Distractors in Adolescent Mice. | Contarini G et al. | β | 2019 | β |
| Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism. | Zieba J et al. | β | 2019 | β |
| Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology. | Rodrigues RS et al. | β | 2019 | β |
| Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder. | Wu MM et al. | β | 2019 | β |
| Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice. | Kruk-Slomka M et al. | β | 2019 | β |
| Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence. | Centanni SW et al. | β | 2019 | β |
| Influence of behavioral traits in the inter-individual variability of nociceptive, emotional and cognitive manifestations of neuropathic pain. | MartΓnez-Navarro M et al. | β | 2019 | β |
| Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats. | Nawata Y et al. | β | 2019 | β |
| Lipopolysaccharide-induced depressive-like, anxiogenic-like and hyperalgesic behavior is attenuated by acute administration of Ξ±-(phenylselanyl) acetophenone in mice. | Sabedra Sousa FS et al. | β | 2019 | β |
| Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2. | MartΓnez-Torres S et al. | β | 2019 | β |
| Opposing roles of CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptors in the stimulant and rewarding effects of cocaine. | Gobira PH et al. | β | 2019 | β |
| Use of the Vsoc-maze to Study Sociability and Preference for Social Novelty in Rodents. | MartΓnez-Torres S et al. | β | 2019 | β |
| 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. | Baggelaar MP et al. | β | 2018 | β |
| Astroglial CB<sub>1</sub> Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory. | Robin LM et al. | β | 2018 | β |
| Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. | LΓΆtsch J et al. | β | 2018 | β |
| Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors. | Aida J et al. | β | 2018 | β |
| Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease. | Llorente-Ovejero A et al. | β | 2018 | β |
| FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats. | Flannery LE et al. | β | 2018 | β |
| Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol. | Busquets-Garcia A et al. | β | 2018 | β |
| Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice. | Cavener VS et al. | β | 2018 | β |
| Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. | Hill MN et al. | β | 2018 | β |
| Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex. | Portero-Tresserra M et al. | β | 2018 | β |
| Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators. | Clapper JR et al. | β | 2018 | β |
| Monoacylglycerol lipase (MAGL) as a promising therapeutic target. | Gil-OrdΓ³Γ±ez A et al. | β | 2018 | β |
| Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication. | Haijen E et al. | β | 2018 | β |
| Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure. | Rivera P et al. | β | 2018 | β |
| Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly. | Quiroga AD et al. | β | 2018 | β |
| The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors. | Reynoso-Moreno I et al. | β | 2018 | β |
| Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. | Bedse G et al. | β | 2018 | β |
| The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. | Griebel G et al. | β | 2018 | β |
| Ξ±-(phenylselanyl) acetophenone abolishes acute restraint stress induced-comorbid pain, depression and anxiety-related behaviors in mice. | Sousa FSS et al. | β | 2018 | β |
| 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex. | Almeida-Santos AF et al. | β | 2017 | β |
| Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity. | Sun L et al. | β | 2017 | β |
| Anxious behavior induces elevated hippocampal Cb<sub>2</sub> receptor gene expression. | Robertson JM et al. | β | 2017 | β |
| Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB<sub>1</sub> and CB<sub>2</sub> receptors. | Stern CAJ et al. | β | 2017 | β |
| Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1. | Ratano P et al. | β | 2017 | β |
| CB<sub>1</sub> Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal. | Saravia R et al. | β | 2017 | β |
| Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease. | Pasquarelli N et al. | β | 2017 | β |
| Differential impact of treadmill training on stroke-induced neurological disorders. | Rezaei R et al. | β | 2017 | β |
| Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. | Bluett RJ et al. | β | 2017 | β |
| Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review. | Kruk-Slomka M et al. | β | 2017 | β |
| Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. | Bedse G et al. | β | 2017 | β |
| Genome-wide expression and response to exposure-based psychological therapy for anxiety disorders. | Roberts S et al. | β | 2017 | β |
| Increase in cortical endocannabinoid signaling in a rat model of basal forebrain cholinergic dysfunction. | Llorente-Ovejero A et al. | β | 2017 | β |
| Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice. | Negrete R et al. | β | 2017 | β |
| Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses. | Wang Y et al. | β | 2017 | β |
| Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling. | Grabner GF et al. | β | 2017 | β |
| Ribosomal Protein S6 Phosphorylation Is Involved in Novelty-Induced Locomotion, Synaptic Plasticity and mRNA Translation. | Puighermanal E et al. | β | 2017 | β |
| Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks. | Silveira MM et al. | β | 2017 | β |
| The cannabinoid system and pain. | Woodhams SG et al. | β | 2017 | β |
| The Endocannabinoid System and Anxiety. | Lisboa SF et al. | β | 2017 | β |
| The endocannabinoid system as a target for novel anxiolytic drugs. | Patel S et al. | β | 2017 | β |
| The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit. | Zubedat S et al. | β | 2017 | β |
| URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy. | Wang D et al. | β | 2017 | β |
| 2-arachidonoylglycerol signaling impairs short-term fear extinction. | Hartley ND et al. | β | 2016 | β |
| 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors. | Granchi C et al. | β | 2016 | β |
| A cannabinoid link between mitochondria and memory. | Hebert-Chatelain E et al. | β | 2016 | β |
| Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats. | Toczek M et al. | β | 2016 | β |
| Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels. | Jenniches I et al. | β | 2016 | β |
| Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands. | Kruk-Slomka M et al. | β | 2016 | β |
| Developmental regulation of fear learning and anxiety behavior by endocannabinoids. | Lee TT et al. | β | 2016 | β |
| Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats. | Panlilio LV et al. | β | 2016 | β |
| Effects of pregabalin on the nociceptive, emotional and cognitive manifestations of neuropathic pain in mice. | La Porta C et al. | β | 2016 | β |
| Examination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26. | Thanos PK et al. | β | 2016 | β |
| FAAH inhibitor OL-135 disrupts contextual, but not auditory, fear conditioning in rats. | Burman MA et al. | β | 2016 | β |
| Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease. | Celorrio M et al. | β | 2016 | β |
| Glutamatergic stimulation induces GluN2B translation by the nitric oxide-Heme-Regulated eIF2Ξ± kinase in cortical neurons. | Ramos-FernΓ‘ndez E et al. | β | 2016 | β |
| In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048). | Aaltonen N et al. | β | 2016 | β |
| Involvement of the orexin/hypocretin system in the pharmacological effects induced by Ξ(9) -tetrahydrocannabinol. | Flores Γ et al. | β | 2016 | β |
| Neurobiological Interactions Between Stress and the Endocannabinoid System. | Morena M et al. | β | 2016 | β |
| Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation. | Busquets-Garcia A et al. | β | 2016 | β |
| 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. | Llorente-Berzal A et al. | β | 2015 | β |
| Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. | Zhang Z et al. | β | 2015 | β |
| Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. | Bernal-Chico A et al. | β | 2015 | β |
| Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission. | Kim J et al. | β | 2015 | β |
| Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. | ViΓ±als X et al. | β | 2015 | β |
| Effects of CB1 receptor agonism and antagonism on behavioral fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats. | Simone JJ et al. | β | 2015 | β |
| Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial. | Schrieks IC et al. | β | 2015 | β |
| Endocannabinoids and Mental Disorders. | Rubino T et al. | β | 2015 | β |
| Endocannabinoids and striatal function: implications for addiction-related behaviours. | Moreira FA et al. | β | 2015 | β |
| Genetic Manipulation of the Endocannabinoid System. | Zimmer A | β | 2015 | β |
| Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase. | Navia-Paldanius D et al. | β | 2015 | β |
| Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption. | Pradier B et al. | β | 2015 | β |
| Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice. | Aliczki M et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2Ξ± Kinase HRI Induces Synaptogenesis. | Ill-Raga G et al. | β | 2015 | β |
| Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. | La Porta C et al. | β | 2015 | β |
| Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents. | Griebel G et al. | β | 2015 | β |
| Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice. | Gong Y et al. | β | 2015 | β |
| The endocannabinoid system in guarding against fear, anxiety and stress. | Lutz B et al. | β | 2015 | β |
| The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs--A practical view. | Fowler CJ | β | 2015 | β |
| The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review. | Fowler CJ | β | 2015 | β |
| The role of the endocannabinoid system in pain. | Woodhams SG et al. | β | 2015 | β |
| A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. | McLaughlin RJ et al. | β | 2014 | β |
| Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus. | Yang K et al. | β | 2014 | β |
| Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy. | Ma L et al. | β | 2014 | β |
| Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. | Pertwee RG | β | 2014 | β |
| Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. | Basavarajappa BS et al. | β | 2014 | β |
| Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice. | Roberts CJ et al. | β | 2014 | β |
| Enzyme inhibitor discovery by activity-based protein profiling. | Niphakis MJ et al. | β | 2014 | β |
| Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. | Shonesy BC et al. | β | 2014 | β |
| Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. | HorvΓ‘th E et al. | β | 2014 | β |
| Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs. | Batista LA et al. | β | 2014 | β |
| In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. | Ignatowska-Jankowska BM et al. | β | 2014 | β |
| Localization of peroxisome proliferator-activated receptor alpha (PPARΞ±) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus. | Rivera P et al. | β | 2014 | β |
| Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament. | FernΓ‘ndez-Aranda F et al. | β | 2014 | β |
| Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. | Zhong P et al. | β | 2014 | β |
| Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. | FernΓ‘ndez-SuΓ‘rez D et al. | β | 2014 | β |
| No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids. | Hu SS et al. | β | 2014 | β |
| Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. | Murataeva N et al. | β | 2014 | β |
| Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice. | Schlosburg JE et al. | β | 2014 | β |
| Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats. | Coria SM et al. | β | 2014 | β |
| Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. | Hermanson DJ et al. | β | 2014 | β |
| Synthesis of phenoxyacyl-ethanolamides and their effects on fatty acid amide hydrolase activity. | Faure L et al. | β | 2014 | β |
| The endocannabinoid system: an emotional buffer in the modulation of memory function. | Morena M et al. | β | 2014 | β |
| The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. | Tchantchou F et al. | β | 2014 | β |
| Amygdala FAAH and anandamide: mediating protection and recovery from stress. | Gunduz-Cinar O et al. | β | 2013 | β |
| Chemical probes of endocannabinoid metabolism. | Blankman JL et al. | β | 2013 | β |
| Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats. | Rivera P et al. | β | 2013 | β |
| Dissociation of the pharmacological effects of THC by mTOR blockade. | Puighermanal E et al. | β | 2013 | β |
| Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice. | Ramesh D et al. | β | 2013 | β |
| Endocannabinoid system and drug addiction: new insights from mutant mice approaches. | Maldonado R et al. | β | 2013 | β |
| Endocannabinoid system and mood disorders: priming a target for new therapies. | Micale V et al. | β | 2013 | β |
| Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats. | MΓ©ndez-DΓaz M et al. | β | 2013 | β |
| Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. | Niphakis MJ et al. | β | 2013 | β |
| Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. | Almeida-Santos AF et al. | β | 2013 | β |
| Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans. | Fagundo AB et al. | β | 2013 | β |
| Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice. | Aliczki M et al. | β | 2013 | β |
| Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice. | Costola-de-Souza C et al. | β | 2013 | β |
| Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase. | Aaltonen N et al. | β | 2013 | β |
| Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects. | Kinsey SG et al. | β | 2013 | β |
| Role of murine models in psychiatric illness drug discovery: a dimensional view. | Hoffman KL | β | 2013 | β |
| Targeting the cannabinoid system for pain relief? | Chiou LC et al. | β | 2013 | β |
| Targeting the endocannabinoid system in the treatment of fragile X syndrome. | Busquets-Garcia A et al. | β | 2013 | β |
| The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. | Campos AC et al. | β | 2013 | β |
| The endocannabinoid system and the brain. | Mechoulam R et al. | β | 2013 | β |
| The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model. | Ghosh S et al. | β | 2013 | β |
| Therapeutic potential of monoacylglycerol lipase inhibitors. | Mulvihill MM et al. | β | 2013 | β |
| Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. | Hill MN et al. | β | 2013 | β |
| 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. | Jung KM et al. | β | 2012 | β |
| Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. | Luchicchi A et al. | β | 2012 | β |
| Cannabinoid receptors: nomenclature and pharmacological principles. | Console-Bram L et al. | β | 2012 | β |
| Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. | Tambaro S et al. | β | 2012 | β |
| Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids. | Puighermanal E et al. | β | 2012 | β |
| Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice. | Wise LE et al. | β | 2012 | β |
| Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. | Naidoo V et al. | β | 2012 | β |
| Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates. | Chang JW et al. | β | 2012 | β |
| Monoacylglycerol lipase - a target for drug development? | Fowler CJ | β | 2012 | β |
| N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze. | John CS et al. | β | 2012 | β |
| O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors. | Niphakis MJ et al. | β | 2012 | β |
| Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. | Pertwee RG | β | 2012 | β |